Novo Socius Pharma Llp - Company Profile

It is a chemicals limited liability partnership based in Ambala Cantt, Haryana, India, established in 2015.
2015 Ambala Cantt, Haryana, India Active
Last Updated:
Access Report
About Novo Socius Pharma Llp

Novo Socius Pharma Llp, a active limited liability partnership, was established on 18 March 2015 in Ambala Cantt, Haryana, India. Engaging in chemicals and chemical products within the chemicals sector, it holds LLPIN: AAD-5628. Registered under ROC Roc Delhi. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Harjit Bali (Designated Partner), Yogesh Kumar Sharma (Designated Partner), Jatinder Sahni (Designated Partner). Its latest date of accounts and solvency statement 31 March 2018. It is based at House No. 61-B, Mati Dass Nagar, Ambala Cantt, Haryana, 133001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAD-5628

  • Incorporation Date

    18 March 2015

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 10 Year, 10 Months
  • Last Filing with ROC 31 Mar 2018
Company report

Novo Socius Pharma Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Novo Socius Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Novo Socius Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Harjit Bali Designated Partner 18 Mar 2015 Current
Yogesh Kumar Sharma Designated Partner 18 Mar 2015 Current
Jatinder Sahni Designated Partner 18 Mar 2015 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Novo Socius Pharma Llp.

Enhance accessibility to Novo Socius Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Novo Socius Pharma Llp revenue growth over time
Novo Socius Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Novo Socius Pharma Llp?

Unlock access to Novo Socius Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Novo Socius Pharma Llp?

Unlock and access historical data on people associated with Novo Socius Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Novo Socius Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novo Socius Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Novo Socius Pharma Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Novo Socius Pharma Llp last Annual general meeting of members was held on 31 Mar 2018 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    The activity Novo Socius Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Delhi. was completed.

  • Director Appointment

    The activity Harjit Bali was appointed as a Designated Partner was appointed as a Designated Partner on 18 Mar 2015 & has been associated with this company since 10 years 10 months . was completed.

  • Director Appointment

    Yogesh Kumar Sharma was appointed as a Designated Partner was appointed as a Designated Partner on 18 Mar 2015 & has been associated with this company since 10 years 10 months . was recorded as a recent event.

  • Director Appointment

    Jatinder Sahni was appointed as a Designated Partner was appointed as a Designated Partner on 18 Mar 2015 & has been associated with this company since 10 years 10 months . was recorded as a recent event.

  • LLP Incorporation

    The activity Novo Socius Pharma Llp was registered on 18 Mar 2015 with Roc Delhi & aged 10 years 10 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Novo Socius Pharma Llp?

The LLPIN of Novo Socius Pharma Llp is AAD-5628.

Where is Novo Socius Pharma Llp headquartered?

Novo Socius Pharma Llp is headquartered at House No. 61-B, Mati Dass Nagar, Ambala Cantt, Haryana, 133001.

When was Novo Socius Pharma Llp incorporated?

Novo Socius Pharma Llp was incorporated on 18 March 2015.

Who are the current directors of Novo Socius Pharma Llp?

The current directors of Novo Socius Pharma Llp are

What is the primary industry of Novo Socius Pharma Llp?

The primary industry of Novo Socius Pharma Llp is Chemicals.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available